Meloximed Forte

Meloxicam, the active ingredient in Meloximed Forte, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis and acute musculoskeletal conditions, and is prescribed for adult patients requiring anti‑inflammatory therapy.

GNH USA supplies Meloximed Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide through regulated distribution channels. All batches meet EU pharmacopeial standards and are shipped with full documentation.

Meloxicam acts on inflammatory pathways to alleviate symptoms in several musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and improves mobility in patients with degenerative joint disease. - Rheumatoid arthritis: diminishes systemic inflammation and joint damage in autoimmune arthritis. - Acute musculoskeletal pain: provides rapid relief of pain and swelling following injury or overuse.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs. - Elevated blood pressure. - Skin rash or pruritus.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal impairment or failure. - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis). - Significant elevation of liver enzymes or hepatic injury.

Before prescribing meloxicam, clinicians should consider several safety measures to minimize risk.

- Assess renal function: evaluate baseline kidney parameters and monitor during therapy. - Monitor hepatic status: check liver enzymes before initiation and periodically thereafter. - Evaluate cardiovascular risk: use cautiously in patients with history of heart disease or stroke. - Avoid in active peptic ulcer disease: consider alternative therapy for patients with gastrointestinal lesions. - Use lowest effective dose: prescribe the minimal dose needed for symptom control. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function. - Diuretics: potential for electrolyte imbalance and renal impairment. - Lithium or methotrexate: possible increase in drug levels and toxicity.